Mobocertinib
CAS: 1847461-43-1
Ref. 3D-XYC46143
2mg | 138,00 € | ||
5mg | 194,00 € | ||
10mg | 310,00 € | ||
25mg | 472,00 € | ||
50mg | 646,00 € |
Informação sobre produto
Mobocertinib is an anti-cancer drug that binds to the epidermal growth factor receptor (EGFR) and inhibits its activity. It is used in the treatment of solid tumours, including those that are resistant to platinum-based chemotherapy. Mobocertinib has been shown to be potent against a range of cancers, both pediatric and adult, including cancer tissues from urothelial carcinoma, PD-L1 positive non-small cell lung cancer (NSCLC), and NSCLC with pd-l1 negative status. Using LC-MS/MS, the pharmacokinetics of mobocertinib have been determined in human plasma. The drug binds tightly to plasma proteins such as albumin and alpha 1 acid glycoprotein (AAG). Mobocertinib is metabolized by CYP3A4 and CYP3A5 into active metabolites.
Propriedades químicas
Consulta técnica sobre: 3D-XYC46143 Mobocertinib
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.